Related Experiment Videos
The AhpC and AhpD antioxidant defense system of Mycobacterium tuberculosis
P J Hillas1, F S del Alba, J Oyarzabal
1Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, California 94143-0446, USA.
Insights
Mycobacterium tuberculosis possesses two alkylhydroperoxidases, AhpC and AhpD, crucial for antioxidant defense. Their unique structures and functions offer potential new strategies against tuberculosis.
Area of Science:
- Biochemistry
- Microbiology
- Molecular Biology
Background:
- Mycobacterium tuberculosis (M. tuberculosis) relies on antioxidant defense systems to survive oxidative stress.
- Peroxiredoxins are key enzymes in cellular defense against reactive oxygen species.
Purpose of the Study:
- To characterize two alkylhydroperoxidases, AhpC and AhpD, from M. tuberculosis.
- To investigate their enzymatic activity and potential role in the antioxidant defense of M. tuberculosis.
- To explore their suitability as targets for novel anti-tuberculosis strategies.
Main Methods:
- Cloning, expression, and purification of AhpC and AhpD proteins.
- Mutagenesis studies to identify critical cysteine residues in AhpC.
- Enzymatic assays to determine substrate specificity and electron donor requirements.
- Genomic analysis to identify related proteins and regulatory elements.
Main Results:
- M. tuberculosis AhpC possesses three cysteine residues essential for catalytic activity, differing from other known AhpC proteins.
- A second alkylhydroperoxidase, AhpD, was identified in M. tuberculosis, sharing the same promoter as AhpC but lacking sequence identity.
- Both AhpC and AhpD effectively reduce alkylhydroperoxides, with AhpC showing particular efficacy with dithiothreitol as an electron donor.
- Neither protein appears to interact with each other, and their endogenous electron donors remain unidentified.
Conclusions:
- AhpC and AhpD are critical components of the antioxidant defense system in M. tuberculosis.
- These proteins demonstrate distinct biochemical properties and substrate preferences.
- AhpC and AhpD represent potential therapeutic targets for developing new anti-tuberculosis treatments.
Abstract:
The peroxiredoxin AhpC from Mycobacterium tuberculosis has been expressed, purified, and characterized. It differs from other well characterized AhpC proteins in that it has three rather than one or two cysteine residues. Mutagenesis studies show that all three cysteine residues are important for catalytic activity. Analysis of the M. tuberculosis genome identified a second protein, AhpD, which has no sequence identity with AhpC but is under the control of the same promoter. This protein has also been cloned, expressed, purified, and characterized. AhpD, which has only been identified in the genomes of mycobacteria and Streptomyces viridosporus, is shown here to also be an alkylhydroperoxidase. The endogenous electron donor for catalytic turnover of the two proteins is not known, but both can be turned over with AhpF from Salmonella typhimurium or, particularly in the case of AhpC, with dithiothreitol. AhpC and AhpD reduce alkylhydroperoxides more effectively than H(2)O(2) but do not appear to interact with each other. These two proteins appear to be critical elements of the antioxidant defense system of M. tuberculosis and may be suitable targets for the development of novel anti-tuberculosis strategies.